February 2 (SeeNews) - Swiss pharmaceutical group Novartis increased its investments in Slovenia to 346 million euro ($381 million) in 2022 from 289 million euro in the previous year in a bid to strengthen its local development and production capacity, its Slovenian subsidiary Lek said.